Haibo Lei

Dr. Haibo Lei


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2024 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
KCKe-Qian Chen
Ke-Qian Chen
SWShuzhi Wang
Shuzhi Wang
HLHaibo Lei
Haibo Lei
XLXiang Liu
Xiang Liu
Oxeiptosis is a novel cell death pathway that was introduced in 2018. As a form of regulated cell death, it operates independently of caspases and is induced by ROS. Distinguished from other cell death pathways such as apoptosis, necroptosis, pyroptosis, and ferroptosis, oxeiptosis features unique damage causes pivotal genes, and signaling pathways (KEAP1/PGAM5/AIFM1). Emerging studies indicate that oxeiptosis plays a significant role in the progression of various diseases and its regulation could serve as a promising therapeutic target. However, the precise molecular mechanisms underlying oxeiptosis remain to be fully elucidated. In this mini-review, we systematically summarize the latest developments in oxeiptosis-related diseases while detailing the molecular mechanisms and regulatory networks of oxeiptosis. These insights offer a foundation for a deeper understanding of oxeiptosis.

18 July 2024 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
KCKe-Qian Chen
Ke-Qian Chen
SWShuzhi Wang
Shuzhi Wang
HLHaibo Lei
Haibo Lei
XLXiang Liu
Xiang Liu
Background: Ophiopogon D is an important natural organic compound in Ophiopogon japonicus, which often has significant biological activity.Purpose: The purpose of this review is to systemically summarize and discuss the pharmacological activity and underlying mechanisms of OP-D in recent years.Method: PubMed and Web of Science were searched with the keywords:“Ophiopogon japonicus”, “Ophiopogon D” “pharmacology”, and “pharmacokinetics”. There was no restriction on the publication year, and the last search was conducted on 1 Jan 2024.Results: Emerging evidence suggests that OP-D possess numerous pharmacological activities, including bone protection, cardiovascular protection, immune regulation, anti-cancer, anti-atherosclerosis, anti-inflammatory and anti-NAFLD.Conclusion: OP-D has a potential value in the prevention and treatment of many diseases. We hope that this review will contribute to therapeutic development and future studies of OP-D.

1 September 2024 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
KCKe-Qian Chen
Ke-Qian Chen
SWShu-Zhi Wang
Shu-Zhi Wang
HLHaibo Lei
Haibo Lei
XLXiang Liu
Xiang Liu
Background: Dauricine is an important natural organic compound in Menispermum dauricum, which often has significant biological activity. Purpose: The purpose of this review is to systemically summarize and discuss the pharmacological activity and underlying mechanisms of dauricine in recent years. Methods: Web of Science (121 articles) and PubMed databases (97 articles) were used to search for articles related to “dauricine” published from 2000 to 2024. Meanwhile, we classified the pharmacological activity of dauricine by screening these articles. Results: Emerging evidence suggests that dauricine possesses numerous pharmacological activities, including neuroprotection, anti-cancer, anti-arrhythmia, anti-inflammatory and anti-diabetes. Conclusion: Dauricine has a potential value in the treatment of many diseases. We hope that this review will contribute to therapeutic development and future studies of dauricine.

9 July 2024 in Heliyon
Verified
Journal Article
Open access
KCKe-Qian Chen
Ke-Qian Chen
HLHaibo Lei
Haibo Lei
XLXiang Liu
Xiang Liu
SWShuzhi Wang
Shuzhi Wang
E2F7 is a recently discovered member of the E2F family. Investigating the function and mechanism of E2F7 in the growth of tumors is significant for the clinical diagnosis and therapy of these malignancies. The purpose of this review is to provide theoretical basis for the diagnosis and treatment of malignant tumors by exploring E2F7. The relevant information was collected through the PubMed database using keyword searches “E2F7” and “cancer”. On the one hand, E2F7 plays an essential role in embryonic development, angiogenesis, and the nervous system. On the other hand, E2F7 is also linked to the occurrence and growth of various malignant tumors. E2F7 has potential as a therapeutic target in future cancer treatments.

12 January 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
NHNan Huang
Nan Huang
ZLZheng Liu
Zheng Liu
HLHaibo Lei
Haibo Lei
XLXiang Liu
Xiang Liu
In the tumor microenvironment (TME), stress-induced mitochondrial DNA (mtDNA) leakage activates the mtDNA-cyclic GMP-AMP synthase (cGAS)- stimulator of interferon genes (STING) axis, which exerts a “double-edged sword” role in tumor immunity. On the one hand, it activates the STING- interferon regulatory factor 3 (IRF3) pathway via cyclic GMP-AMP (cGAMP) synthesis by cGAS, induces type I interferons (IFN-I), enhances the cytotoxic functions of CD8 + T cells and natural killer (NK) cells as well as the antigen-presenting capacity of dendritic cells (DCs), and also promotes M1 macrophage polarization and neutrophil extracellular trap (NETs) formation, thereby driving immune activation. On the other hand, sustained activation of this axis can induce programmed cell death ligand 1 (PD-L1) expression, recruit myeloid-derived suppressor cells (MDSCs), and cause T cells exhaustion, facilitating tumor immune evasion. Targeting mtDNA stability, constructing nano-drug delivery systems, or combining with immune checkpoint blockade can reshape the tumor immune microenvironment and provide new ideas for precision immunotherapy. This article systematically summarizes the dual effects of this axis on the tumor immune microenvironment, which not only deepens the understanding of cancer immunology but also provides guidance for the research, development, and optimization of precision tumor immunotherapies, and is expected to improve patient prognosis.

27 June 2024 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
PDF file
KCKe-Qian Chen
Ke-Qian Chen
SWShuzhi Wang
Shuzhi Wang
HLHaibo Lei
Haibo Lei
XLXiang Liu
Xiang Liu
Necrostatin-1, a small molecular alkaloid, was identified as an inhibitor of necroptosis in 2005. Investigating the fundamental mechanism of Necrostatin-1 and its role in various diseases is of great significance for scientific and clinical research. Accumulating evidence suggests that Necrostatin-1 plays a crucial role in numerous neurological disorders. This review aims to provide a comprehensive overview of the potential functions of Necrostatin-1 in various neurological disorders, offering valuable insights for future research.